Search clinical trials for: Angiomax (bivalirudin)

Total 84 results

The Medicines Company

Completed

Bivalirudin as a Procedural Anticoagulant in Pediatrics

Cardiology
NYU Langone Health
Guerbet

Completed

Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography

Coronary Artery Disease

United States
Regado Biosciences, Inc.
Icahn School of Medicine at Mount Sinai; The Cleveland Clinic; Parexel; Duke Clinical... and other collaborators

Terminated

A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI (Regulate)

Coronary Artery Disease

United States
The Medicines Company

Completed

Angiomax in Patients With HIT/HITTS Type II Undergoing CPB (HIT/TS)

Cardiovascular Disease | Coronary Artery Bypass Surgery

United States
The Medicines Company

Completed

Study Of Angiomax In Infants Under Six Months With Thrombosis

Thrombosis

United States
The Medicines Company

Terminated

Bivalirudin Infusion for Ventricular Infarction Limitation (BIVAL)

Acute Myocardial Infarction

Netherlands, France
The Medicines Company

Completed

Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCI

Myocardial Infarction

United States
The Medicines Company

Completed

Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)

Myocardial Infarction | Acute Disease | Unstable Angina

United States
The Medicines Company

Completed

European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial (EUROMAX)

Acute Coronary Syndrome

Denmark, Netherlands, Italy, France, Germany, Poland, Austria, Czech Republic, Slovenia
The Medicines Company

Completed

Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)

Thrombosis | Thrombocytopenia | Cardiac Disease | Coronary Artery Bypass Surgery

United States
The Medicines Company

Terminated

ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial (ENDOMAX)

Bleeding | Peripheral Endovascular Interventions

United States
The Medicines Company

Completed

Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH (BRAVO 2/3)

Transcatheter Aortic Valve Replacement | Aortic Valve Replacement | Severe Aortic Stenosis

Netherlands, Germany, United Kingdom, Canada, France, Italy, Switzerland
Children's Hospital Los Angeles
Baylor College of Medicine; Children's Hospital of Philadelphia; Children's Hospital... and other collaborators

Completed

The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids (UNBLOCK)

Deep Venous Thrombosis

United States
Qian Gong

Unknown

Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI)

Coronary Heart Disease
Johns Hopkins University

Withdrawn

Bivalirudin vs Heparin in ECMO Patients

Extracorporeal Membrane Oxygenation Complication

United States
Stony Brook University

Terminated

Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention (STATUS PCI)

Coronary Artery Disease

United States
Laval University

Unknown

EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding (EASY-B2B)

Coronary Artery Disease

Canada
Uppsala University
Lund University

Completed

Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART (VALIDATE)

ST-segment Elevation Myocardial Infarction | Non ST-segment Elevation Myocardial Infarction

Sweden
Legacy Health System
Pacific University

Unknown

Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation (BIV-ECMO2)

Extracorporeal Membrane Oxygenation Complication | Anticoagulants

United States
Juan J Badimon
AstraZeneca

Completed

Antithrombotic Effects of Ticagrelor Versus Clopidogrel

Acute Coronary Syndrome

United States
Clinica Mediterranea

Completed

Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients (NAPLESIII)

Bleeding

Italy
Nanjing First Hospital, Nanjing Medical University

Completed

Safety and Efficacy of Prolonged Use of Bivalirudin 4 Hours After ePCI (COBER Study)

Coronary Heart Disease

China
Angiodynamics, Inc.

Completed

Initial Experience With the AngioVac Venous Drainage Cannula

Heart Disease

United States
Istituto Clinico Sant'Ambrogio
Istituto Clinico Humanitas; Azienda Ospedaliera Niguarda Cà Granda; Centro Cardiologico...

Unknown

Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI

ST-Elevation Myocardial Infarction | Primary Percutaneous Coronary Intervention

Italy
Liverpool Heart and Chest Hospital NHS Foundation...

Completed

How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention (HEAT-PPCI)

Acute ST Elevation Myocardial Infarction

United Kingdom
The Medicines Company

Withdrawn

Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

Heparin-Induced Thrombocytopenia | Heparin-induced Thrombocytopenia and Thrombosis Syndrome

United States
Italian Society of Invasive Cardiology
Eustrategy

Unknown

Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX)

STEMI | Acute Coronary Syndromes | NSTEMI

Italy
Pieris Pharmaceuticals GmbH
FGK Clinical Research GmbH

Completed

Study of Angiocal® in Patients With Solid Tumors, Investigating Safety, Tolerability, Blood Concentration of Study Drug

Solid Tumor

Germany
Hamad Medical Corporation

Unknown

Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial

Anticoagulation in COVID-19 ARDS

Qatar
The Medicines Company

Completed

Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)

Thrombosis | Heparin-Induced Thrombocytopenia

United States
Chinese PLA General Hospital

Unknown

Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI

Coronary Disease

China
Nycomed

Withdrawn

RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)

Coronary Disease
Cardiovascular Research Foundation, New York
Boston Scientific Corporation; The Medicines Company

Completed

Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction

Myocardial Infarction

United States
Changhai Hospital
Wuhan University; Qilu Hospital of Shandong University; The First Affiliated... and other collaborators

Unknown

Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms (BUILD)

Subarachnoid Hemorrhage, Aneurysmal
LifeBridge Health

Unknown

Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin

Coronary Artery Disease

United States
Deutsches Herzzentrum Muenchen

Completed

Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome (ISAR-REACT-4)

Myocardial Infarction | Coronary Disease

Germany, Italy
Careggi Hospital

Completed

Antithrombotic Regimens and Outcome (ARNO)

Coronary Artery Disease

Italy
Azienda Ospedaliera San Camillo Forlanini

Unknown

FIT (Fast Infarction Treatment): Complete Revascularization During Primary Percutaneous Coronary Intervention (PCI) Can be Achieved Safely With an Improved Clinical Outcome During the Indexed Hospitalization. (FIT)

Myocardial Infarction | Ischemia | Necrosis | Heart Failure | Stents

Italy
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

L-Arginine Supplements in Treating Women Who Are Cancer Survivors

Sexual Dysfunction | Unspecified Adult Solid Tumor, Protocol Specific | Sexuality and Reproductive Issues

United States
Maastricht University Medical Center
Leiden University Medical Center

Unknown

L-arginine and Brown Adipose Tissue (ArgMB)

Glucose Intolerance | Nitric Oxide | Adipose Tissue, Brown

Netherlands
Peking University First Hospital

Recruiting

A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation. (PCI)

Coronary Microvascular Dysfunction

China
Xijing Hospital

Unknown

Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty

ST-elevation Myocardial Infarction

China
Sunshine Lake Pharma Co., Ltd.

Not yet recruiting

A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China

Diabetes
NYU Langone Health

Recruiting

A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction

Myocardial Ischemia | Ischemic Heart Disease | Coronary Microvascular Disease

United States
Xiaotong Hou

Not yet recruiting

Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation

Extracorporeal Membrane Oxygenation Complication

China
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors

Prostate Cancer | Radiation Toxicity | Male Erectile Disorder

United States
Xijing Hospital

Unknown

Cocktail Injection Improves Outcomes of FFR Guided PCI (CocktailII)

Acute Coronary Syndromes

China
Medstar Health Research Institute
GlaxoSmithKline

Completed

Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI (SWITCHIII)

Acute Coronary Syndromes

United States, Canada
Centre Hospitalier de PAU

Terminated

Anticoagulant Treatments and Percutaneous Coronary Angioplasty (TACA)

Coronary Artery Disease

France
HaEmek Medical Center, Israel

Completed

ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding (ACRIPAB)

Hematologic Diseases

Israel

Search clinical trials for: Angiomax (bivalirudin)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations